| 000 | 01720 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513115227.0 | ||
| 264 | 0 | _c19970716 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0960-7404 | ||
| 024 | 7 |
_a10.1016/s0960-7404(96)80028-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIwase, K | |
| 245 | 0 | 0 |
_aIndirect inhibitory effect of a neurotensin receptor antagonist on human colon cancer (LoVo) growth. _h[electronic resource] |
| 260 |
_bSurgical oncology _c |
||
| 300 |
_a245-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Northern |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 |
_aColonic Neoplasms _xpathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aNeoplasm Transplantation |
| 650 | 0 | 4 |
_aNeurotensin _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
| 650 | 0 | 4 |
_aRNA, Neoplasm _xanalysis |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aReceptors, Neurotensin _xanalysis |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aTransplantation, Heterologous |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 700 | 1 | _aEvers, B M | |
| 700 | 1 | _aHellmich, M R | |
| 700 | 1 | _aKim, H J | |
| 700 | 1 | _aHigashide, S | |
| 700 | 1 | _aGully, D | |
| 700 | 1 | _aTownsend, C M | |
| 773 | 0 |
_tSurgical oncology _gvol. 5 _gno. 5-6 _gp. 245-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0960-7404(96)80028-4 _zAvailable from publisher's website |
| 999 |
_c9110655 _d9110655 |
||